Methergine
NDC Package 55289-708-20
Package Information
Methergine is a medication used after childbirth to help stop bleeding from the uterus. Marketed by Pd-rx Pharmaceuticals, Inc., this product is identified by NDC 55289-708 and is authorized under FDA application NDA006035.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55289 - Pd-rx Pharmaceuticals, Inc.
- 55289-708 - Methergine
- 55289-708-20 - 20 TABLET, COATED in 1 BOTTLE, PLASTIC
- 55289-708 - Methergine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (55289-708). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55289-708-20 identifies a specific commercial package of 20 tablet, coated in 1 bottle, plastic of Methergine, labeled by Pd-rx Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pd-rx Pharmaceuticals, Inc. on November 19, 1946. The current certification is valid through April 13, 2016.
What are the primary indications for this medication?
This medication is used after childbirth to help stop bleeding from the uterus. Methylergonovine belongs to a class of drugs known as ergot alkaloids. It works by increasing the rate and strength of contractions and the stiffness of the uterus muscles. These effects help to decrease bleeding.
How is this Pd-rx Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55289070820. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
